Clinical
by design.
Every ingredient at the dose used in the clinical trials that support it. No decoration dosing. No vague outcomes. The formula that should have existed.
Shop Metabolic Reset
Pharmacist-formulated
Efficacious dosing
Full transparency
Evidence-based
Pharmacist precision meets commercial clarity. The formula is built on the same evidence framework used in clinical prescribing, applied to a category that has long settled for less.
A New Zealand-qualified pharmacist with over a decade in clinical and community pharmacy. Thussheeta's formulation approach applies the same evidence framework used in therapeutic prescribing. Every dose in Metabolic Reset was set by Thussheeta against the primary clinical evidence.
Swain
Ayas's experience navigating rising LDL, blood pressure, and HbA1c at 30 became the founding brief. He encountered the same gap Thussheeta had been watching from the clinic, a category with credible ingredients at non-credible doses. He is the original customer the formula was built for.
Pharmacist formulas built to the dose that appeared in the trial.
Each formula is built from the clinical evidence up. Every ingredient selected because it addresses a distinct metabolic pathway. Every dose set to match the amount used in the primary RCT that supports its inclusion, not reduced to fit a price point or a label strategy.
How we select ingredients
Selection starts with a metabolic pathway gap. From there, the literature is reviewed for ingredients with RCT-level evidence addressing that pathway. An ingredient is considered for inclusion only if the primary evidence comes from a randomised controlled trial and the active dose used in that trial is achievable inside the final product's format.
This is why Metabolic Reset contains six ingredients: berberine, green tea extract, ginger extract, resveratrol, chromium, and B420® probiotic, not sixteen. Six pathways with meaningful doses. Adding more would require reducing doses. Reducing doses would undermine the clinical rationale for including them.
How we set doses
Each dose is set to match the amount used in the primary clinical evidence supporting that ingredient's inclusion. For B420®, the Stenman et al. 2016 RCT used 10 billion CFU daily. That is the dose in the formula. Not rounded, not adjusted for cost. The same dose used in the evidence.
If the clinical rationale cannot be reproduced at an achievable dose, the ingredient is removed from the formula entirely. This is the only standard Maison Belasi formulates to.
What we refuse to include
Proprietary blends: where ingredients are listed without individual amounts. This practice exists to allow brands to include headline ingredients at any dose, including negligible ones, without disclosure. Maison Belasi does not use proprietary blends. Every ingredient is on the label at its exact amount.
Decoration dosing: including an ingredient at a dose far below what the clinical evidence used. If the amount is not the amount that appeared in the trial, it does not belong on a clinical credibility claim.
An ingredient that cannot be absorbed cannot work.
Two ingredients in Metabolic Reset use proprietary delivery systems specifically because the standard form of the molecule has documented bioavailability limitations. The delivery system is not a marketing claim. It determines whether the ingredient works.
BioBerb® with LipiSperse®: Berberine
Standard berberine is subject to active efflux in the intestinal epithelium, where P-glycoprotein and other transporters pump the molecule back into the intestinal lumen before it can be absorbed. Oral bioavailability of standard berberine hydrochloride is estimated below 5% in some studies.
LipiSperse® is a lipid-based dispersion technology in which berberine is encased in a lipid matrix, reducing its recognition by efflux transporters and improving mucosal permeability. BioBerb® combines berberine with LipiSperse® technology, achieving comparable or superior plasma levels at a lower total dose than standard berberine.
B420®: clinically characterised probiotic strain
Probiotic strains are not interchangeable. The clinical evidence for B420® applies specifically to this strain, characterised by its genome, growth behaviour, and documented interaction with gut epithelial tight junction proteins. A different strain of Bifidobacterium lactis, at the same dose, does not carry the same evidence.
This is why Metabolic Reset uses the B420® strain by name and by certificate of analysis, not a generic "Bifidobacterium lactis" that could refer to any of hundreds of characterised strains.
Committing to the highest standards in formulation.
We back every product with clinical research and full label transparency so you can verify what is in the formula before you buy. The standard is pharmacist-set, evidence-based, and unchanged regardless of cost pressure.
Clinical research methodology
Every inclusion backed by peer-reviewed RCT data. The formulation process for Metabolic Reset began with the published literature, not with a target ingredient list. Each inclusion was reviewed against available RCT data. Each dose was set to match the amount used in the primary trial, not reduced to fit a price point or a capsule count. Full references are available on request and on the clinical references page.
Pharmacist oversight
All formulation decisions are made by Thussheeta Singh, a registered New Zealand pharmacist with over a decade in clinical practice. Her formulation framework is the same applied in therapeutic prescribing: evidence first, dose to match the evidence, no inclusion without clinical rationale. The pharmacist credential is a verifiable, protected claim. It is not marketing copy.
Full label transparency
No proprietary blends. Every ingredient is on the label at its exact dose. Every amount is verifiable against the published evidence before you purchase. The label is a commitment, not a marketing document. If an ingredient cannot be disclosed at its full dose, it does not belong in the formula.